Accumulating evidence has suggested that tight coupling of the ErbB4–PSD-95–NMDA receptor complex may underlie the pathophysiological molecular signature of psychiatric and cognitive disorders [11–13]. Here, ERBB4 is linked to Cognitive impairment.